Classification

WHO Grade

Features

Well-differentiated neuroendocrine tumor, grade 1

G1

<2 mitoses per 10 HPF

Ki67 labeling index <2%

Well-differentiated neuroendocrine tumor, grade 2

G2

2 - 20 mitoses per 10 HPF

Ki67 labeling index 3% - 20%

Poorly-differentiated neuroendocrine carcinoma (small cell carcinoma, large cell endocrine carcinoma), grade 3

G3

>20 mitoses per 10 HPF

Ki67 labeling index >20%